Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ligand Pharmaceuticals Inc.    LGND

LIGAND PHARMACEUTICALS INC. (LGND)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Ligand Pharmaceuticals Inc. : SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Ligand Pharmaceuticals Incorporated

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/17/2013 | 06:55pm CET

NEW YORK, May 17, 2013 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Ligand Pharmaceuticals Incorporated (NasdaqGM: LGND), and its Board of Directors, in connection with possible claims of breaches of fiduciary duty.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)

To get more information, click here: http://zlk.9nl.com/ligand-pharmaceuticals-lgnd/. There is no cost or obligation to you.

If you own common stock in Ligand Pharmaceuticals Incorporated and wish to obtain additional information, please contact Eduard Korsinsky, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/ligand-pharmaceuticals-lgnd/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP


© PRNewswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LIGAND PHARMACEUTICALS INC
02/21LIGAND PHARMACEUTICALS : reports 4Q loss
AQ
02/21LIGAND PHARMACEUTICALS INC : Results of Operations and Financial Condition (form..
AQ
02/21LIGAND PHARMACEUTICALS : Reports Fourth Quarter and Full Year 2017 Financial Res..
BU
02/21LIGAND PHARMACEUTICALS INC. : Ligand Pharmaceuticals Incorporated to Host Earnin..
AC
02/05LIGAND PHARMACEUTICALS : to Report Fourth Quarter and Full Year 2017 Results on ..
BU
01/30LIGAND PHARMACEUTICALS INCORPORATED : LGND) Files An 8-K Departure of Directors..
AQ
01/29LIGAND PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K..
AQ
01/25LIGAND PHARMACEUTICALS : Establishes Program to Develop Captisol-Enabled, Next-G..
AQ
01/24LIGAND PHARMACEUTICALS : Establishes program to develop captisol-enabled next-ge..
AQ
01/22LIGAND PHARMACEUTICALS : Enters into Worldwide OmniAb® Platform License Agreemen..
BU
More news
News from SeekingAlpha
02/23YOUR DAILY PHARMA SCOOP : Dynavax Achieves Major Milestone, GW Pharmaceuticals G.. 
02/21Ligand Pharmaceuticals' (LGND) CEO John Higgins on Q4 2017 Results - Earnings.. 
02/21Ligand Pharmaceuticals beats by $0.17, beats on revenue 
02/20Notable earnings after Wednesday?s close 
02/13Merck bails on Alzheimer's candidate verubecestat